Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · May 25, 2023

Clemastine and Remyelination

Proceedings of the National Academy of Sciences of the United States of America

 

Additional Info

Disclosure statements are available on the authors' profiles:

Proceedings of the National Academy of Sciences of the United States of America
MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial
Proc. Natl. Acad. Sci. U.S.A 2023 May 16;120(20)e2217635120, E Caverzasi, N Papinutto, C Cordano, G Kirkish, TJ Gundel, A Zhu, AV Akula, WJ Boscardin, H Neeb, RG Henry, JR Chan, AJ Green

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading